These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 6373933

  • 1. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
    Fidler IJ, Schroit AJ.
    J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
    [Abstract] [Full Text] [Related]

  • 2. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
    Sone S, Fidler IJ.
    J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
    [Abstract] [Full Text] [Related]

  • 3. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
    Fidler IJ, Barnes Z, Fogler WE, Kirsh R, Bugelski P, Poste G.
    Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I, Fidler IJ.
    J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
    [Abstract] [Full Text] [Related]

  • 6. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.
    Fidler IJ, Raz A, Fogler WE, Kirsh R, Bugelski P, Poste G.
    Cancer Res; 1980 Dec; 40(12):4460-6. PubMed ID: 7002293
    [Abstract] [Full Text] [Related]

  • 7. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S, Tachibana K, Shono M, Ogushi F, Tsubura E.
    J Biol Response Mod; 1984 Dec; 3(2):185-94. PubMed ID: 6726281
    [Abstract] [Full Text] [Related]

  • 8. Isolation of tumoricidal macrophages from lung melanoma metastases of mice treated systemically with liposomes containing a lipophilic derivative of muramyl dipeptide.
    Key ME, Talmadge JE, Fogler WE, Bucana C, Fidler IJ.
    J Natl Cancer Inst; 1982 Nov; 69(5):1198-98. PubMed ID: 6957661
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
    Phillips NC, Chedid L, Bernard JM, Level M, Lefrancier P.
    J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
    [Abstract] [Full Text] [Related]

  • 11. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
    Sone S, Tsubura E.
    J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
    [Abstract] [Full Text] [Related]

  • 12. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
    Daemen T, Veninga A, Roerdink FH, Scherphof GL.
    Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
    [Abstract] [Full Text] [Related]

  • 13. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
    Poste G, Kirsh R, Fogler WE, Fidler IJ.
    Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
    [Abstract] [Full Text] [Related]

  • 14. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines.
    Sone S, Poste G, Fidler IJ.
    J Immunol; 1980 May; 124(5):2197-202. PubMed ID: 7365253
    [Abstract] [Full Text] [Related]

  • 15. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ, Fidler IJ.
    Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
    [Abstract] [Full Text] [Related]

  • 16. Preparation and antitumor effect of macrophage activating factor (MAF) encapsulated in liposomes bearing a monoclonal anti-human melanoma (A375) antibody.
    Watanabe Y, Uchida E, Higuchi M, Imai Y, Osawa T.
    J Biol Response Mod; 1987 Oct; 6(5):556-68. PubMed ID: 3316511
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative.
    Phillips NC, Tsao MS.
    Cancer Res; 1989 Feb 15; 49(4):936-9. PubMed ID: 2912563
    [Abstract] [Full Text] [Related]

  • 18. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
    Sone S, Mutsuura S, Ogawara M, Tsubura E.
    J Immunol; 1984 Apr 15; 132(4):2105-10. PubMed ID: 6699409
    [Abstract] [Full Text] [Related]

  • 19. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
    Fidler IJ, Raz A, Fogler WE, Hoyer LC, Poste G.
    Cancer Res; 1981 Feb 15; 41(2):495-504. PubMed ID: 7004633
    [Abstract] [Full Text] [Related]

  • 20. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ, Fogler WE, Kleinerman ES, Saiki I.
    J Immunol; 1985 Dec 15; 135(6):4289-96. PubMed ID: 3934281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.